(Press-News.org) Previous depression, daily smoking and a lack of control over life circumstances — or "low mastery" — are risk factors for repeat episodes of depression, states an article in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/site/embargo/cmaj110676.pdf.
Depression is a common disorder that negatively affects quality of life for people with the condition. About 65% of people with depression have repeat episodes. Depression can be associated with weight and dietary control, pain and inattention to other health issues.
To identify risk factors associated with a long-term prognosis of depression, researchers looked at 585 adults from Statistics Canada's National Population Health Survey who had suffered depression in 2000/01. Of the patients, 65% were women, the average age was 38.5 years, and 82% were in the middle- to high-income bracket. More than half the patients had one or more episodes of depression in the following six years. Being an immigrant appeared to have protective status against relapse in people with severe depression.
The researchers found that age, sex and income were not associated with future depressive episodes but that daily smoking and low mastery were associated with long-term depression. Mastery is the sense that people have control over their lives and their circumstances. In this study, high levels of mastery appeared to be protective against further depression.
"History of depression is a well-known clinical indicator of future depressive episodes; however, smoking and mastery are more novel prognostic factors that are not well accounted for in current clinical practice," states Dr. Ian Colman, Department of Epidemiology and Community Medicine, University of Ottawa, with coauthors.
"Future research should evaluate the benefits of including smoking cessation and mastery in existing clinical guidelines for the treatment of depression," they conclude.
### END
Daily smoking, low mastery associated with repeat episodes of depression
2011-10-25
ELSE PRESS RELEASES FROM THIS DATE:
Impact of Canada's Common Drug Review on drug listing
2011-10-25
The number of drugs covered by public drug plans decreased substantially after Canada's Common Drug Review was introduced in 2003, and new drugs were listed more quickly in several of the smaller provinces, found a study published in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/site/embargo/cmaj110670.pdf.
Canada has 19 public drug plans, which accounted for about 39% of the forecasted $31 billion in drug-related costs in 2010. These plans cover the cost of a range of drugs prescribed to patients. Before 2003, each plan independently ...
Statewide Solutions NJ Now Certified in Mold Remediation
2011-10-25
Statewide Solutions NJ is proud to announce that they are now certified in Mold Remediation by NORMI; the National Organization of Remediators and Mold Inspectors.
The certification is earned by taking part in rigorous training and passing a certification exam to ensure thorough understanding of EPA and industry standard protocols for mold assessment and remediation. Some of the information covered during training includes microbial remediation standards, mold equipment calibration and operation, safety procedures, contact with regulated substances, preventing cross ...
Consumers don't pay as much attention to nutrition fact labels as they think
2011-10-25
Philadelphia, PA, October 24, 2011 – Nutrition Facts labels have been used for decades on many food products. Are these labels read in detail by consumers when making purchases? Do people read only certain portions of the labels? According to a new study published in the November issue of the Journal of the American Dietetic Association, consumers' self-reported viewing of Nutrition Facts label components was higher than objectively measured viewing using an eye-tracking device. Researchers also determined that centrally located Nutrition Facts labels are viewed more frequently ...
Exposure to chemical BPA before birth linked to behavioral, emotional difficulties in girls
2011-10-25
Boston, MA – Exposure in the womb to bisphenol A (BPA) – a chemical used to make plastic containers and other consumer goods – is associated with behavior and emotional problems in young girls, according to a study led by researchers at Harvard School of Public Health (HSPH), Cincinnati Children's Hospital and Medical Center, and Simon Fraser University in Vancouver, British Columbia.
BPA is found in many consumer products, including canned food linings, polycarbonate plastics, dental sealants, and some receipts made from thermal paper. Most people living in industrialized ...
More time outdoors may reduce kids' risk for nearsightedness
2011-10-25
ORLANDO, Fla. –October 24, 2011– A new analysis of recent eye health studies shows that more time spent outdoors is related to reduced rates of nearsightedness, also known as myopia, in children and adolescents. Myopia is much more common today in the United States and many other countries than it was in the 1970s. In parts of Asia, more than 80 percent of the population is nearsighted. The analysis suggests that more exposure to natural light and/or time spent looking at distant objects may be key factors. Today at the 115th Annual Meeting of the American Academy of Ophthalmology ...
Vitamin B-based treatment for corneal disease may offer some patients a permanent solution
2011-10-25
ORLANDO, Fla. – October 24, 2011 – Patients in the United States who have the cornea-damaging disease keratoconus may soon be able to benefit from a new treatment that is already proving effective in Europe and other parts of the world. The treatment, called collagen crosslinking, improved vision in almost 70 percent of patients treated for keratoconus in a recent three-year clinical trial in Milan, Italy. The treatment is in clinical trials in the United States and is likely to receive FDA approval in 2012. The results of the Milan study are being presented today at the ...
AFP Brandywine Chapter Announces Annual Philanthropy Day Winners
2011-10-25
Brandywine Chapter of the Association of Fundraising Professionals (AFP) is pleased to announce the winners of the 2011 Philanthropy Day Awards: Sonia Schorr Sloan, Jane Wilkie, Barclay's Bank and Matthew Ryan McNeill. The winners will be honored on Wednesday, November 16th during the Chapter's annual Philanthropy Day activities being held at Deerfield Golf and Tennis Club.
Sonia Schorr Sloan of Brandywine Hundred is receiving the Professional Life-Time Achievement Award for decades of service to numerous organizations. Sonia was instrumental in the founding of a number ...
Surprises of the measles virus structure
2011-10-25
Professor Sarah Butcher's research group from Helsinki University's Institute of Biotechnology report in the 24th October online issue of the journal Proceedings of the National Academy of Sciences (U.S.A.) a three-dimensional model of measles virus. The new model helps to explain many previous, unaccounted for observations in the life cycle of the virus.
Measles is an important disease worldwide that is highly infectious, causing the deaths of over 100000 people annually. According to the latest figures from the World Health Organisation, 33 countries in Europe have ...
Study hints at possible therapeutic strategy to combat premature birth
2011-10-25
CINCINNATI – Scientists who developed a novel mouse model mimicking human preterm labor have described a molecular signaling pathway underlying preterm birth and targeted it to stop the problem.
In a study to be published online the week of Oct. 24 by PNAS (Proceedings of the National Academy of Sciences), the researchers report their findings may lead to new strategies for combating this major global health issue in humans. The study was led by scientists in the division of Reproductive Sciences and Perinatal Institute at Cincinnati Children's Hospital Medical Center.
They ...
Mayo Clinic detective work shows possible side effect in macular degeneration drug
2011-10-25
ROCHESTER, Minn. -- Two major drug trials conclude there was little risk from a drug aimed at age-related macular degeneration. Yet a Mayo Clinic ophthalmologist began to note something concerning in some of her patients: an increase in pressure inside the eye. It led to a retrospective study and findings that will be presented at the American Academy of Ophthalmology in Orlando.
Sophie Bakri, M.D., had been treating patients in her clinic with Food and Drug Administration-approved ranibizumab (Lucentis), when she began noticing a change in some patients.
"I was treating ...